# Pear Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pear-bio

- Industry: Biotechnology
- Headquarters: Canterbury, UK
- Website: www.pearbio.com
- Total disclosed funding: $14M
- Latest round: Series A (May 15, 2023)
- Investors on record: 1

## About

Based in Canterbury, UK, and founded in 2017, Ourotech Ltd, trading under the name Pear Bio provides chips that visualize and compute cancer tumors. In May 2023, investor Octopus Ventures led a USD 14 million in Series A funding for Pear Bio.

The company offers microtumor technology which recreates the core part of the human tumor microenvironment and provides accurate lab testing. The firm’s technology utilizes organ-on-chip and computer vision which combines 3D cell culture, functional testing, computer vision, and multi-omics analysis and model the spread of cancer as well as assess drug impacts on its progression.

The company plans to use the May 2023 funding to further enhance cancer drug treatments.

## Funding rounds

- Series A, May 15, 2023, $14M — Octopus Investments

## Investors

- Octopus Investments (https://capitalatlas.ai/funds/octopus-investments) — Series A